The underused potential of breast conserving therapy after neoadjuvant system treatment: causes and solutions

Breast conserving therapy (BCT), consisting of breast conserving surgery and subsequent radiotherapy, is an equivalent option to mastectomy for women with early breast cancer. Although BCT after neoadjuvant systemic treatment (NAST) has been routinely recommend by international guidelines since many...

Full description

Saved in:
Bibliographic Details
Main Authors: Pfob, André (Author) , Dubsky, Peter (Author)
Format: Article (Journal)
Language:English
Published: 10 February 2023
In: The breast
Year: 2023, Volume: 67, Pages: 110-115
ISSN:1532-3080
DOI:10.1016/j.breast.2023.01.008
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.breast.2023.01.008
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0960977623000085
Get full text
Author Notes:André Pfob, Peter Dubsky

MARC

LEADER 00000caa a2200000 c 4500
001 1840456558
003 DE-627
005 20230706214448.0
007 cr uuu---uuuuu
008 230329s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.breast.2023.01.008  |2 doi 
035 |a (DE-627)1840456558 
035 |a (DE-599)KXP1840456558 
035 |a (OCoLC)1389531081 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfob, André  |e VerfasserIn  |0 (DE-588)1167798945  |0 (DE-627)1031607064  |0 (DE-576)51127338X  |4 aut 
245 1 4 |a The underused potential of breast conserving therapy after neoadjuvant system treatment  |b causes and solutions  |c André Pfob, Peter Dubsky 
264 1 |c 10 February 2023 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 17. Januar 2023, Artikelversion 10. Februar 2023 
500 |a Gesehen am 29.03.2023 
520 |a Breast conserving therapy (BCT), consisting of breast conserving surgery and subsequent radiotherapy, is an equivalent option to mastectomy for women with early breast cancer. Although BCT after neoadjuvant systemic treatment (NAST) has been routinely recommend by international guidelines since many years, the rate of BCT worldwide varies largely and its potential is still underused. While the rate of BCT in western countries has increased over the past decades to currently about 70%, the rate of BCT is as low as 10% in other countries. In this review, we will evaluate the underused potential of breast conservation after NAST, identify causes, and discuss possible solutions. We identified clinical and non-clinical causes for the underuse of BCT after NAST including uncertainties within the community regarding oncologic outcomes, the correct tumor localization after NAST, the management of multifocal and multicentric tumors, margin assessment, disparities of socio-economic aspects on a patient and national level, and psychological biases affecting the shared decision-making process between patients and clinicians. Possible solutions to mitigate the underuse of BCT after NAST include interdisciplinary teams that keep the whole patient pathway in mind, optimized treatment counseling and shared decision-making, and targeted financial support to alleviate disparities. 
650 4 |a Breast conserving therapy 
650 4 |a Health equity 
650 4 |a Neoadjuvant systemic treatment 
700 1 |a Dubsky, Peter  |e VerfasserIn  |0 (DE-588)1244925594  |0 (DE-627)177595384X  |4 aut 
773 0 8 |i Enthalten in  |t The breast  |d Amsterdam [u.a.] : Elsevier, 1992  |g 67(2023) vom: Feb., Seite 110-115  |h Online-Ressource  |w (DE-627)320475042  |w (DE-600)2009043-2  |w (DE-576)103868151  |x 1532-3080  |7 nnas  |a The underused potential of breast conserving therapy after neoadjuvant system treatment causes and solutions 
773 1 8 |g volume:67  |g year:2023  |g month:02  |g pages:110-115  |g extent:6  |a The underused potential of breast conserving therapy after neoadjuvant system treatment causes and solutions 
856 4 0 |u https://doi.org/10.1016/j.breast.2023.01.008  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0960977623000085  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230329 
993 |a Article 
994 |a 2023 
998 |g 1167798945  |a Pfob, André  |m 1167798945:Pfob, André  |d 910000  |d 910400  |e 910000PP1167798945  |e 910400PP1167798945  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1840456558  |e 429956720X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"The underused potential of breast conserving therapy after neoadjuvant system treatment causes and solutionsThe breast","note":["Gesehen am 27.04.2020","Fortsetzung der Druck-Ausgabe"],"recId":"320475042","id":{"eki":["320475042"],"zdb":["2009043-2"],"issn":["1532-3080"]},"part":{"pages":"110-115","volume":"67","extent":"6","text":"67(2023) vom: Feb., Seite 110-115","year":"2023"},"pubHistory":["1.1992 -"],"origin":[{"dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisher":"Elsevier ; Harcourt","publisherPlace":"Amsterdam [u.a.] ; Burlington, Mass."}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"breast","title":"The breast"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["André Pfob, Peter Dubsky"]},"note":["Online verfügbar 17. Januar 2023, Artikelversion 10. Februar 2023","Gesehen am 29.03.2023"],"recId":"1840456558","id":{"doi":["10.1016/j.breast.2023.01.008"],"eki":["1840456558"]},"person":[{"given":"André","role":"aut","display":"Pfob, André","family":"Pfob"},{"family":"Dubsky","role":"aut","display":"Dubsky, Peter","given":"Peter"}],"title":[{"title":"The underused potential of breast conserving therapy after neoadjuvant system treatment","subtitle":"causes and solutions","title_sort":"underused potential of breast conserving therapy after neoadjuvant system treatment"}],"physDesc":[{"extent":"6 S."}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"10 February 2023"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a PFOBANDREDUNDERUSEDP1020